Упрощенная HTML-версия
160
fith, et al. // Am. J. Resp. Crit. Care Med. – 1999. – Vol. 159 (4). – p. 1249-
1256.
79. Hoffken G. The importance of a de-escalating strategy for antibiotic treat-
ment of pneumonia in the ICU / G. Hoffken, M.S. Niederman // Chest. –
2002. – Vol. 23 – p. 2183-2196.
80.Horan T.C. Nosocomial infections in surgical patients in the United States,
January 1986 - June 1992. National Nosocomial Infections Surveillance
(NNIS) System / T.C. Horan, D.H. Culver, R.P. Gaynes, W.R. Jarvis, J.K.
Edwards, C.R. Reid // Infect. Control. Hosp. Epidemiol. - 1993. - Vol. 14. –
p. 73-80.
81.Hubmayr R.D. Statement of the 4
th
International Consensus Conference in
Critical Care in ICU Acquired Pneumonia, Illinois, May, 2002 / R.D. Hub-
mayr // Intensive Care Med. – 2002. – Vol. 8. – p. 1521-1536.
82.Ibrahim E.H. A comparative analysis of patients with early-onset vs late-
onset nosocomial pneumonia in the ICU setting / E.H. Ibrahim, S. Ward, G.
Sherman // Chest. – 2000. – Vol. 117. – p. 1434-1442.
83.Ibrahim E.H. Experience with a clinical guideline for the treatment of venti-
lator-associated pneumonia / E.H. Ibragim, S. Ward, G. Sherman, R. Schaiff,
V.J. Fraser, M.H. Kollef // Crit. Care Med. - 2001. - Vol. 29. - p. 1109-1115.
84.Ikei S. Blood concentration of polymorphonuclear leukocyte elastase and in-
terleukin-6 are indicatorsfor the occurrence of multiple organ failures at the
early stage of acute pancreatitis / S. Ikei, M. Ogawa // J. Gastroenterol Hepa-
tol. – 1998. – Vol. 13. – p. 1274-1283.
85.Iregui M. Clinical importance of delays in the initiation of appropriate anti-
biotic treatment for ventilator – associated pneumonia / M. Iregui, S. Ward //
Chest. – 2002. – Vol. 122. – p. 262-268.
86.Jones C.E. Interleukin-17 stimulates the expression of interleukin-8, growth-
related oncogene-alpha, and granulocyte-colonystimulating factor by human